Skip to main content

Advertisement

Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Higher cardiometabolic risk in idiopathic versus autoimmune type 1 diabetes: a retrospective analysis

Fig. 1

a Beta cell function assessed through glucagon stimulated C-peptide (GSC-pep) test at times 0–1–3–6–10 and 15 min in patients with idiopathic (IDM) and autoimmune (ADM) type 1 diabetes at onset, after metabolic stabilization. b Area under curve (AUC) of GSC-pep 15 min in patients with IDM and ADM at onset, after metabolic stabilization. C. GSC-pep peak in patients with IDM and ADM at onset, after metabolic stabilization

Back to article page